## Core Concept
The Revised National Tuberculosis Control Programme (RNTCP) in India, now known as the National Tuberculosis Elimination Programme (NTEP), categorizes patients into different groups based on their treatment history and sputum smear results. Category 1 (Cat-1) includes new smear-positive patients, new smear-negative patients with extensive pulmonary TB, and patients with severe forms of extra-pulmonary TB.

## Why the Correct Answer is Right
For RNTCP Cat-1 patients, the recommended treatment regimen is **2(EHRZ) + 4(EHR)**, which translates to two months of isoniazid (H), rifampicin (R), pyrazinamide (Z), and ethambutol (E), followed by four months of isoniazid, rifampicin, and ethambutol. This regimen is crucial for effectively treating drug-susceptible TB and preventing the development of drug resistance.

## Why Each Wrong Option is Incorrect
- **Option A:** Incorrect because it does not accurately represent the Cat-1 treatment regimen as per RNTCP guidelines.
- **Option B:** Incorrect because, although it includes some correct drugs, it does not match the duration or combination specified for Cat-1 patients.
- **Option D:** Incorrect because it suggests a regimen that is not aligned with the standard treatment protocol for new TB patients under RNTCP.

## Clinical Pearl / High-Yield Fact
A key point to remember is that the RNTCP Cat-1 regimen is **2(EHRZ) + 4(EHR)**, making option **C. 2(EHRZ) + 4(EHR)** the correct choice. This standardized treatment approach is critical for TB elimination efforts.

## Correct Answer Line
**Correct Answer: C. 2(EHRZ) + 4(EHR)**